iCAD to Present Corporate Overview at the 31st Annual Roth Conference
NASHUA,
N.H. — March 14, 2019 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing
innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief
Executive Officer, and Stacey Stevens, Chief Strategy & Commercial Officer,
will be meeting with investors in a one-on-one format at the 31st Annual ROTH
Conference, being held March 17-19 in Laguna Niguel, California.
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a
global medical technology leader providing innovative cancer detection and
therapy solutions. For more information, visit www.icadmed.com.
Contact:
Investor
Relations:
LifeSci
Advisors
Jeremy
Feffer
(212)
915-2568
or:
Media
Inquiries:
ARPR,
on behalf of iCAD, Inc.
Paul Barren
(855) 300-8209